Finance

Lists
Q2 2027 earnings • released • EPS beat +7.33% • Revenue beat +10.23%
See results
EMAMILTD:NSE
Emami Ltd
₹387.50
-0.14%
(-0.55) 1D
Nov 6, 3:30:02 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for EMAMILTD...
Open
₹385.00
High
₹392.90
Low
₹380.10
Mkt. cap
169.14B
Avg. vol.
1.20M
Volume
554.60K
Dividend
2.58%
Quarterly dividend
₹2.50
Ex-dividend date
Feb 10, 2026
P/E ratio
22.59
52-wk high
₹550.90
52-wk low
₹357.00
EPS
₹17.15
Shares outstanding
453.94M
No. of employees
3K
Open
₹385.00
High
₹392.90
Low
₹380.10
Mkt. cap
169.14B
Avg. vol.
1.20M
Volume
554.60K
Dividend
2.58%
Quarterly dividend
₹2.50
Ex-dividend date
Feb 10, 2026
P/E ratio
22.59
52-wk high
₹550.90
52-wk low
₹357.00
EPS
₹17.15
Shares outstanding
453.94M
No. of employees
3K
News stories
From web sources and news partners
Profile
Emami Group is an Indian multinational conglomerate headquartered in Kolkata. The company caters to a number of niche categories in the personal care and healthcare segments. The company's products are sold across 60+ nations and are available in 4.5 million retail outlets across India. The company has seven manufacturing units across India and one overseas unit. Among its prominent brands is an antiseptic cream named BoroPlus. The company's skin care division generated an overall revenue of ₹2,655 crores in the financial year 2019–20 with an annual profit of ₹639 crores. The total group revenue of the company stands at ₹20,000 crores. Wikipedia
About Emami Ltd
CEOSudhakar Rao Desai
Employees3.1K
Founded1974
Headquarters-
SectorConsumer Staples
IndustryPersonal care products
Websiteemamiltd.in
Last report
Nov 5, 2026
Fiscal period
Q2 2027
₹3.66 / ₹3.41
+7.33%beat
Revenue / Est. (INR)
10.88B / 9.87B
+10.23%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
7.99B
11.52B
9.25B
10.39B
Cost of goods sold
2.31B
3.38B
3.31B
3.55B
Cost of revenue
2.31B
3.38B
3.31B
3.55B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.78B
3.13B
3.42B
3.39B
Operating expense
4.34B
4.75B
4.43B
5.01B
Total operating expenses
6.65B
8.13B
7.74B
8.56B
Operating income
1.33B
3.39B
1.51B
1.83B
Other non operating income
213.70M
189.70M
-592.95M
185.00M
EBT including unusual items
1.50B
3.45B
1.64B
1.95B
EBT excluding unusual items
1.50B
3.55B
1.21B
1.95B
Income tax expense
18.30M
255.70M
208.99M
557.70M
Effective tax rate
1.22%
7.41%
12.74%
28.64%
Other operating expenses
1.11B
1.17B
588.30M
1.19B
Net income
1.48B
3.19B
1.43B
1.37B
Net profit margin
18.58%
27.74%
15.48%
13.22%
Earnings per share
3.92
7.54
3.67
3.46
Interest and investment income
-
-
321.25M
-
Interest expense
-26.30M
-29.20M
-31.50M
-56.10M
Net interest expenses
-26.30M
-29.20M
289.75M
-56.10M
Depreciation and amortization charges
222.30M
222.80M
226.62M
239.90M
EBITDA
1.74B
3.79B
1.91B
2.23B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps